VectivBio_Logo_RGB_Color.png
VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals
26 juin 2023 16h01 HE | VectivBio AG
BASEL, Switzerland, June 26, 2023 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a global clinical-stage biopharmaceutical company pioneering novel, transformational...